Anamed PermaVision
This article was originally published in The Gray Sheet
Executive Summary
Removable, intracorneal lens implant Phase II study go-ahead from FDA includes 100 eyes at five sites with up to +6 diopters of hyperopia, the firm says. The lens is placed under a corneal flap made with a microkeratome in a reversible, sutureless procedure. The flap is similar to ones in non-reversible LASIK refractive procedures, according to Lake Forest, Calif.-based Anamed...